SCHEMBL8312581

SCHEMBL8312581

O=C(c1ccc(Nc2nccc(-c3ccc(Cl)cc3)n2)cc1)N1CCC(NC2CC2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 2/20 0.58
PIK3CA P42336 2/20 0.52
PIK3CB P42338 2/20 0.52
PIK3CG P48736 2/20 0.52
IKBKB O14920 9/20 0.50
CHUK O15111 5/20 0.50
CDK2 P24941 1/20 0.50
IKBKG Q9Y6K9 4/20 0.49
MEN1 O00255 1/20 0.49
RECQL P46063 1/20 0.49
BLM P54132 1/20 0.49
KMT2A Q03164 1/20 0.49
PRKCZ Q05513 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
JAK2 O60674 2/20 0.48
CAMK2D Q13557 3/20 0.48
HDAC3 O15379 1/20 0.48
NCOR1 O75376 1/20 0.48
JAK1 P23458 1/20 0.48
TYK2 P29597 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8308878 0.95 CDK1 (0.53) CDK1PIK3CAPIK3CBPIK3CGIKBKB
SCHEMBL8254568 0.90 JAK2 (0.55) PIK3CAPIK3CBPIK3CGIKBKBCHUK
SCHEMBL4074601 0.90 IKBKB (0.50) CDK1PIK3CAPIK3CBPIK3CGIKBKB
SCHEMBL13590857 0.90 CDK1 (0.54) CDK1PIK3CAPIK3CBPIK3CGIKBKB
SCHEMBL11924743 0.89 GRM5 (0.60) CDK1PIK3CAPIK3CBPIK3CGIKBKB
SCHEMBL4396304 0.89 IKBKB (0.53) PIK3CAPIK3CBPIK3CGIKBKBCHUK
Hydrochloric Acid SCHEMBL4071661 0.89 CDK1 (0.53) CDK1PIK3CAPIK3CBPIK3CGIKBKB
Hydrochloric Acid SCHEMBL4066207 0.88 IKBKB (0.53) PIK3CAPIK3CBPIK3CGIKBKBCHUK
SCHEMBL8258444 0.88 IKBKB (0.50) CDK1PIK3CAPIK3CBPIK3CGIKBKB
SCHEMBL14021219 0.88 PIK3CA (0.58) PIK3CAPIK3CBPIK3CGIKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed